The Chemotherapy Use and Adverse Effects of Patients With Lung Cancer at Regional General Hospital in Surabaya, Indonesia

This study assessed chemotherapy use and adverse effects in 41 adult lung cancer patients at a hospital in Surabaya, Indonesia, finding that all chemotherapy regimens were appropriate per treatment guidelines. Most patients (87.80%) received first-line chemotherapy, with pemetrexed-cisplatin and pemetrexed-carboplatin being the most common regimens. Adverse effects were prevalent, affecting 61.11% of first-line and 60% of second-line chemotherapy patients. Anemia was the most frequent delayed adverse effect in first-line therapy, while hair loss was most common in second-line therapy. The study emphasizes the importance of managing chemotherapy-related adverse effects to enhance treatment outcomes.